Ligand (LGND) Breakout! Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Ligand (LGND) Breakout!

LGND 189.93

+0.5%

3:59 PM EST

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Henry Niman who wrote (3481)	6/10/1997 8:34:00 AM
From: Hippieslayer	of 32384

This may have already been posted: The May issue of "Skin and Allergy News", a publication for dermatologists, has a front page article describing the phase I/II results of Ligand's LGD1069 (Targretin) in the treatment of mycosis fungoides which is a type of skin cancer. The trial was conducted by Dr. Debra Breneman at the U. of Cincinnati College of Medicine. According to the results, "43% of the patients treated with the topical gel achieved at least 50% clearance". Also, the Dr was quoted as saying "There has been no hypersensitivity (to the gel) shown to date, it can be self-administered, and it is well tolerated over the long term". A total of 27 men and 21 women were enrolled in the study.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next